/PRNewswire/ WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of.
Integra LifeSciences (NASDAQ:IART – Get Rating)‘s stock had its “downgrade” rating reissued by 22nd Century Group in a research report issued to clients and investors on Tuesday, Benzinga reports. Other equities research analysts also recently issued reports about the company. StockNews.com began coverage on Integra LifeSciences in a research report on Thursday, May 18th. They […]
GW&K Investment Management LLC lessened its position in Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Rating) by 0.4% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 764,638 shares of the life sciences company’s stock after selling 2,748 shares during the period. GW&K Investment Management LLC owned approximately […]
Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Rating)’s share price reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as $39.00 and last traded at $40.12, with a volume of 393997 shares trading hands. The stock had previously closed at $40.48. Wall Street Analyst Weigh In Several research […]